Products for Research Use Only
RegisterLogin

PSB069

CAT: 0804-HY-103262-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103262-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PSB069 bearing a p-chlorophenylamino residue is a potent, well-tolerated and nonselective NTPDases1, 2, 3 inhibitor (Ki=16~18 μM) [1].
CAS Number
78510-31-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
NTPDase
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/psb069.html
Purity
99.5
Solubility
DMSO : 45 mg/mL (ultrasonic; warming)
Smiles
O=S(C(C(N)=C1C2=O)=CC(NC3=CC=C(Cl)C=C3)=C1C(C4=C2C=CC=C4)=O)(O[Na])=O
Molecular Formula
C20H12ClN2NaO5S
Molecular Weight
450.83
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Baqi Y, et al. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases) . Purinergic Signal. 2009;5 (1) :91-106.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-103175-01PSB36

Alternative Products

CatalogName
GTR19200967PSB069

Popular Products